ClearPoint Neuro Inc (CLPT)
11.84
+0.74
(+6.72%)
USD |
NASDAQ |
Nov 22, 16:00
11.83
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Cash from Financing (Quarterly): -10.06M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.06M |
| June 30, 2024 | 0.16M |
| March 31, 2024 | 16.05M |
| December 31, 2023 | 0.155M |
| September 30, 2023 | -0.091M |
| June 30, 2023 | 0.237M |
| March 31, 2023 | -0.005M |
| December 31, 2022 | 0.222M |
| September 30, 2022 | -0.329M |
| June 30, 2022 | 0.513M |
| March 31, 2022 | 0.003M |
| December 31, 2021 | 0.048M |
| September 30, 2021 | -0.452M |
| June 30, 2021 | 0.349M |
| March 31, 2021 | 46.93M |
| December 31, 2020 | 7.876M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.764M |
| March 31, 2020 | 14.05M |
| December 31, 2019 | -0.0729M |
| September 30, 2019 | -0.2522M |
| June 30, 2019 | 5.930M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0266M |
| September 30, 2018 | -2.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3268M |
| March 31, 2018 | 0.2051M |
| December 31, 2017 | 0.0088M |
| September 30, 2017 | -0.009M |
| June 30, 2017 | 11.99M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0041M |
| September 30, 2016 | 3.832M |
| June 30, 2016 | 0.1401M |
| March 31, 2016 | -0.1401M |
| December 31, 2015 | 4.879M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 9.380M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 3.646M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.0063M |
| June 30, 2013 | 0.0134M |
| March 31, 2013 | 9.829M |
| December 31, 2012 | 0.0938M |
| September 30, 2012 | 4.528M |
| June 30, 2012 | 0.9895M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-10.06M
Minimum
Sep 2024
46.93M
Maximum
Mar 2021
3.818M
Average
0.1575M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| InfuSystems Holdings Inc | -6.752M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.199M |
| Cash from Investing (Quarterly) | -0.012M |
| Free Cash Flow | -9.076M |
| Free Cash Flow Per Share (Quarterly) | -0.0439 |
| Free Cash Flow to Equity (Quarterly) | 8.768M |
| Free Cash Flow Yield | -2.92% |